The earnings call presented a mix of positive and negative aspects. Revenue growth and a strong order backlog indicate a stable foundation for future growth, while challenges in order bookings and organic revenue growth pose concerns. The company is recognized for excellence and is seeing opportunities in nuclear energy and life sciences, but faces increased SG&A expenses and challenges in U.S. lab research funding.

Company Guidance

During the ATS Corporation's First Quarter Conference Call for Fiscal Year 2026, the company reported Q1 revenues of $737 million, reflecting a 6% increase from the previous year, with order bookings totaling $693 million. The adjusted earnings from operations were $79 million, while the order backlog stood at approximately $2.1 billion. The Life Sciences division contributed significantly, with a backlog of $1.2 billion, driven by wins in auto-injectors, radiopharma, and blood glucose monitoring wearables. The Food and Beverage segment ended the quarter with a backlog of $229 million, marking a 6% increase. Meanwhile, the Energy sector benefited from ongoing CANDU refurbishment activity. The company maintained a trailing 12-month book-to-bill ratio above 1, at 1.7:1, and anticipates Q2 revenues between $700 million to $740 million. ATS also reported a net debt to adjusted EBITDA ratio of 3.6x and plans to reduce this to a target range of 2 to 3x. The company's strategy includes growing repeatable revenue through services, consumables, and digital offerings, alongside strategic M&A to support long-term growth.

Revenue Growth

Q1 revenues were $737 million, up 6% from Q1 last year, with contributions from recent acquisitions and foreign exchange translation.

Strong Order Backlog

Order backlog ended the quarter at approximately $2.1 billion, providing solid revenue visibility and a strong foundation for growth.

Recognition for Excellence

ATS was included in Time Magazine's inaugural list of Canada's best companies 2025, ranking #1 in the engineering, manufacturing, and medical technology category.

Nuclear Energy Opportunities

Continued momentum in nuclear energy with ongoing CANDU refurbishment activity and emerging opportunities in small module reactors.

Life Sciences Success

Life Sciences order backlog at quarter-end was $1.2 billion, with wins across submarkets such as auto-injectors and radiopharma.

Cash Flow and Leverage Improvement

Cash flows from operating activities were $156 million. Net debt to adjusted EBITDA ratio improved to 3.6x, with a focus on reducing leverage further.

ATS Corporation (TSE:ATS) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

TSE:ATS Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 05, 2025	2026 (Q2)	0.43 / -	0.25	―	―	―
Aug 07, 2025	2026 (Q1)	0.44 / 0.41	0.5	-18.00% (-0.09)	―	―
May 28, 2025	2025 (Q4)	0.38 / 0.41	0.65	-36.92% (-0.24)	―	―
Feb 05, 2025	2025 (Q3)	0.35 / 0.32	0.65	-50.77% (-0.33)	―	―
Nov 06, 2024	2025 (Q2)	0.33 / 0.25	0.63	-60.32% (-0.38)	―	―
Aug 08, 2024	2025 (Q1)	0.52 / 0.50	0.69	-27.54% (-0.19)	―	―
May 16, 2024	2024 (Q4)	0.56 / 0.65	0.73	-10.96% (-0.08)	―	―
Feb 07, 2024	2024 (Q3)	0.64 / 0.65	0.52	25.00% (+0.13)	―	―
Nov 08, 2023	2024 (Q2)	0.64 / 0.63	0.5	26.00% (+0.13)	―	―
Aug 09, 2023	2024 (Q1)	0.65 / 0.69	0.64	7.81% (+0.05)	―	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

TSE:ATS Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 07, 2025	C$42.68	C$40.58	-4.92%
May 28, 2025	C$41.93	C$41.68	-0.60%
Feb 05, 2025	C$38.19	C$41.02	+7.41%
Nov 06, 2024	C$42.55	C$40.71	-4.32%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Ats Corporation (TSE:ATS) report earnings?

Ats Corporation (TSE:ATS) is schdueled to report earning on Nov 05, 2025, Before Open (Confirmed).

What is Ats Corporation (TSE:ATS) earnings time?

Ats Corporation (TSE:ATS) earnings time is at Nov 05, 2025, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is TSE:ATS EPS forecast?

TSE:ATS EPS forecast for the fiscal quarter 2026 (Q2) is 0.43.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing